{"entity":{"type":"insider","cik":"0001469124","url":"/insider/0001469124","json_url":"/insider/0001469124.json","name":"Tarriff Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":18,"first":"2015-07-02","last":"2023-11-03","span_basis":"filed_date"},"name_variants":[{"name":"Tarriff Scott","source":"filing","n_filings":18,"first_seen":"2015-07-02","last_seen":"2023-11-03"}],"transactions":[{"id":8630802,"accession":"0001209191-23-054333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054333","line_url":"/filing/0001209191-23-054333#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10694.0,"shares_display":"10,694","price_per_share":13.87,"price_display":"13.87","price_state":"stated","total_value":148325.78,"total_display":"148,325.78","total_whole":"148,326","shares_owned_after":545447.0,"shares_owned_after_display":"545,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":8630799,"accession":"0001209191-23-054333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054333","line_url":"/filing/0001209191-23-054333#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10925.0,"shares_display":"10,925","price_per_share":13.82,"price_display":"13.82","price_state":"stated","total_value":150983.5,"total_display":"150,983.50","total_whole":"150,984","shares_owned_after":556141.0,"shares_owned_after_display":"556,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8658237,"accession":"0001209191-23-052030","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-052030","line_url":"/filing/0001209191-23-052030","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10734.0,"shares_display":"10,734","price_per_share":14.456301471958264,"price_display":"14.46","price_state":"stated","total_value":155173.94,"total_display":"155,173.94","total_whole":"155,174","shares_owned_after":567776.0,"shares_owned_after_display":"567,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider","n_lines":2},{"id":8658226,"accession":"0001209191-23-052030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052030","line_url":"/filing/0001209191-23-052030#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9511.0,"shares_display":"9,511","price_per_share":15.23,"price_display":"15.23","price_state":"stated","total_value":144852.53,"total_display":"144,852.53","total_whole":"144,853","shares_owned_after":577800.0,"shares_owned_after_display":"577,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8294326,"accession":"0001209191-23-030725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030725","line_url":"/filing/0001209191-23-030725#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.98,"price_display":"19.98","price_state":"stated","total_value":299700.0,"total_display":"299,700.00","total_whole":"299,700","shares_owned_after":587311.0,"shares_owned_after_display":"587,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7869799,"accession":"0001209191-23-029625","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-029625","line_url":"/filing/0001209191-23-029625","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":21.066133333333333,"price_display":"21.07","price_state":"stated","total_value":315992.0,"total_display":"315,992.00","total_whole":"315,992","shares_owned_after":1595134.0,"shares_owned_after_display":"1,595,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-15","scope":"insider","n_lines":2},{"id":7869788,"accession":"0001209191-23-029625","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-029625","line_url":"/filing/0001209191-23-029625","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.267624666666666,"price_display":"20.27","price_state":"stated","total_value":304014.37,"total_display":"304,014.37","total_whole":"304,014","shares_owned_after":1609934.0,"shares_owned_after_display":"1,609,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-15","scope":"insider","n_lines":2},{"id":7869780,"accession":"0001209191-23-029625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029625","line_url":"/filing/0001209191-23-029625#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.71,"price_display":"20.71","price_state":"stated","total_value":310650.0,"total_display":"310,650.00","total_whole":"310,650","shares_owned_after":1624934.0,"shares_owned_after_display":"1,624,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider"},{"id":8099551,"accession":"0001209191-19-023147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023147","line_url":"/filing/0001209191-19-023147#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Commn Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24975.0,"shares_display":"24,975","price_per_share":50.15,"price_display":"50.15","price_state":"stated","total_value":1252496.25,"total_display":"1,252,496.25","total_whole":"1,252,496","shares_owned_after":1500202.0,"shares_owned_after_display":"1,500,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":8343147,"accession":"0001209191-19-015645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015645","line_url":"/filing/0001209191-19-015645","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24428.0,"shares_display":"24,428","price_per_share":51.17138857049288,"price_display":"51.17","price_state":"stated","total_value":1250014.68,"total_display":"1,250,014.68","total_whole":"1,250,015","shares_owned_after":1525177.0,"shares_owned_after_display":"1,525,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider","n_lines":2},{"id":7835932,"accession":"0001209191-19-007134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-007134","line_url":"/filing/0001209191-19-007134","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30085.0,"shares_display":"30,085","price_per_share":41.543333887319264,"price_display":"41.54","price_state":"stated","total_value":1249831.2,"total_display":"1,249,831.20","total_whole":"1,249,831","shares_owned_after":1550505.0,"shares_owned_after_display":"1,550,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-04","scope":"insider","n_lines":2},{"id":8116681,"accession":"0001209191-19-002391","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-002391","line_url":"/filing/0001209191-19-002391","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16569.0,"shares_display":"16,569","price_per_share":39.29374253123303,"price_display":"39.29","price_state":"stated","total_value":651058.02,"total_display":"651,058.02","total_whole":"651,058","shares_owned_after":1524362.0,"shares_owned_after_display":"1,524,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider","n_lines":3},{"id":8116672,"accession":"0001209191-19-002391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-002391","line_url":"/filing/0001209191-19-002391","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":39.71366666666667,"price_display":"39.71","price_state":"stated","total_value":595705.0,"total_display":"595,705.00","total_whole":"595,705","shares_owned_after":1534959.0,"shares_owned_after_display":"1,534,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2},{"id":3317433,"accession":"0001209191-16-113116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-113116","line_url":"/filing/0001209191-16-113116#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30765.0,"shares_display":"30,765","price_per_share":40.63,"price_display":"40.63","price_state":"stated","total_value":1249981.95,"total_display":"1,249,981.95","total_whole":"1,249,982","shares_owned_after":1369946.0,"shares_owned_after_display":"1,369,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":2177387,"accession":"0001209191-16-105298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-105298","line_url":"/filing/0001209191-16-105298","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19780.0,"shares_display":"19,780","price_per_share":63.19656016177957,"price_display":"63.20","price_state":"stated","total_value":1250027.96,"total_display":"1,250,027.96","total_whole":"1,250,028","shares_owned_after":1400711.0,"shares_owned_after_display":"1,400,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider","n_lines":2},{"id":2500720,"accession":"0001209191-16-094813","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-094813","line_url":"/filing/0001209191-16-094813","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18360.0,"shares_display":"18,360","price_per_share":68.08139106753812,"price_display":"68.08","price_state":"stated","total_value":1249974.34,"total_display":"1,249,974.34","total_whole":"1,249,974","shares_owned_after":1433484.0,"shares_owned_after_display":"1,433,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-02","scope":"insider","n_lines":5},{"id":2093283,"accession":"0001209191-16-088749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-088749","line_url":"/filing/0001209191-16-088749","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14549.0,"shares_display":"14,549","price_per_share":85.91111828991683,"price_display":"85.91","price_state":"stated","total_value":1249920.86,"total_display":"1,249,920.86","total_whole":"1,249,921","shares_owned_after":1441624.0,"shares_owned_after_display":"1,441,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider","n_lines":2},{"id":8381661,"accession":"0001209191-15-082913","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-082913","line_url":"/filing/0001209191-15-082913","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14050.0,"shares_display":"14,050","price_per_share":88.92661352313168,"price_display":"88.93","price_state":"stated","total_value":1249418.92,"total_display":"1,249,418.92","total_whole":"1,249,419","shares_owned_after":1459900.0,"shares_owned_after_display":"1,459,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-02","scope":"insider","n_lines":5},{"id":8084344,"accession":"0001209191-15-078192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-078192","line_url":"/filing/0001209191-15-078192","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19339.0,"shares_display":"19,339","price_per_share":64.63389575469259,"price_display":"64.63","price_state":"stated","total_value":1249954.91,"total_display":"1,249,954.91","total_whole":"1,249,955","shares_owned_after":1475076.0,"shares_owned_after_display":"1,475,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-03","scope":"insider","n_lines":2},{"id":8926816,"accession":"0001209191-15-073947","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-073947","line_url":"/filing/0001209191-15-073947","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17878.0,"shares_display":"17,878","price_per_share":69.91636284819332,"price_display":"69.92","price_state":"stated","total_value":1249964.735,"total_display":"1,249,964.74","total_whole":"1,249,965","shares_owned_after":1487854.0,"shares_owned_after_display":"1,487,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider","n_lines":5},{"id":8496615,"accession":"0001209191-15-069431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-069431","line_url":"/filing/0001209191-15-069431","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16245.0,"shares_display":"16,245","price_per_share":76.94663219452138,"price_display":"76.95","price_state":"stated","total_value":1249998.04,"total_display":"1,249,998.04","total_whole":"1,249,998","shares_owned_after":1506594.0,"shares_owned_after_display":"1,506,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-03","scope":"insider","n_lines":4},{"id":8375323,"accession":"0001209191-15-063783","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-063783","line_url":"/filing/0001209191-15-063783","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":96.18525076923076,"price_display":"96.19","price_state":"stated","total_value":1250408.26,"total_display":"1,250,408.26","total_whole":"1,250,408","shares_owned_after":1523254.0,"shares_owned_after_display":"1,523,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-04","scope":"insider","n_lines":2},{"id":8774567,"accession":"0001209191-15-058900","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-058900","line_url":"/filing/0001209191-15-058900#line-5","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001469124","owner_name":"Tarriff Scott","owner_display_name":"Tarriff Scott","owner_url":"/insider/0001469124","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6015.0,"shares_display":"6,015","price_per_share":78.98,"price_display":"78.98","price_state":"stated","total_value":475064.7,"total_display":"475,064.70","total_whole":"475,065","shares_owned_after":1537622.0,"shares_owned_after_display":"1,537,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-02","scope":"insider"}],"collapsed":true,"next_cursor":"2015-07-01|8774567","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Director, Officer (CEO), Ten percent owner","n_filings":18,"first_seen":"2015-07-02","last_seen":"2023-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001469124","retrieved_at":"2026-08-22T10:53:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}